- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Hester Biosciences Limited — Updates, 24-01-2026: Press Release
24-01-2026 | 05:07 pm
24-01-2026 | 05:07 pm
Hester Biosciences secured a manufacturing license for its Inactivated Avian Influenza Vaccine (H9N2 strain) for poultry. This enables the company to market a key vaccine that addresses significant economic losses in poultry flocks due to Avian Influenza, boosting its healthcare portfolio.
No comments yet. Be the first to comment!